A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
NCT07609914
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Treatment of Migraine
Interventions
DRUG:
Rimegepant
Sponsor
Pfizer